124 related articles for article (PubMed ID: 7562421)
1. Dielectric analysis in the characterization of amorphous pharmaceutical solids. 1. Molecular mobility in poly(vinylpyrrolidone)-water systems in the glassy state.
Duddu SP; Sokoloski TD
J Pharm Sci; 1995 Jun; 84(6):773-6. PubMed ID: 7562421
[TBL] [Abstract][Full Text] [Related]
2. Low frequency dielectric investigations into the relaxation behavior of frozen polyvinylpyrrolidone-water systems.
Barker SA; He R; Craig DQ
J Pharm Sci; 2001 Feb; 90(2):157-64. PubMed ID: 11169532
[TBL] [Abstract][Full Text] [Related]
3. Probing beta relaxation in pharmaceutically relevant glasses by using DSC.
Vyazovkin S; Dranca I
Pharm Res; 2006 Feb; 23(2):422-8. PubMed ID: 16388410
[TBL] [Abstract][Full Text] [Related]
4. The assessment of the relaxation behaviour of frozen aqueous solutions of human serum albumin and polyvinylpyrrolidine.
Barker SA
Eur J Pharm Biopharm; 2004 May; 57(3):431-9. PubMed ID: 15093590
[TBL] [Abstract][Full Text] [Related]
5. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
Yoshioka S; Aso Y
Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
[TBL] [Abstract][Full Text] [Related]
6. Invertase storage stability and sucrose hydrolysis in solids as affected by water activity and glass transition.
Chen YH; Aull JL; Bell LN
J Agric Food Chem; 1999 Feb; 47(2):504-9. PubMed ID: 10563924
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
8. A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).
Xiang TX; Anderson BD
J Pharm Sci; 2004 Apr; 93(4):855-76. PubMed ID: 14999724
[TBL] [Abstract][Full Text] [Related]
9. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
10. Water mobility in poly(ethylene glycol)-, poly(vinylpyrrolidone)-, and gelatin-water systems, as indicated by dielectric relaxation time, spin-lattice relaxation time, and water activity.
Yoshioka S; Aso Y; Otsuka T; Kojima S
J Pharm Sci; 1995 Sep; 84(9):1072-7. PubMed ID: 8537884
[TBL] [Abstract][Full Text] [Related]
11. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1995 Aug; 84(8):983-6. PubMed ID: 7500284
[TBL] [Abstract][Full Text] [Related]
13. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by (13)C-NMR relaxation time.
Aso Y; Yoshioka S; Zhang J; Zografi G
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):822-6. PubMed ID: 12045339
[TBL] [Abstract][Full Text] [Related]
14. Effect of molecular structure and water content on the dielectric relaxation behaviour of amorphous low molecular weight carbohydrates above and below their glass transition.
Noel TR; Parker R; Ring SG
Carbohydr Res; 2000 Dec; 329(4):839-45. PubMed ID: 11125826
[TBL] [Abstract][Full Text] [Related]
15. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.
Zeng XM; Martin GP; Marriott C
Int J Pharm; 2001 May; 218(1-2):63-73. PubMed ID: 11337150
[TBL] [Abstract][Full Text] [Related]
16. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
Crowley KJ; Zografi G
J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
[TBL] [Abstract][Full Text] [Related]
17. Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP.
Caron V; Bhugra C; Pikal MJ
J Pharm Sci; 2010 Sep; 99(9):3887-900. PubMed ID: 20575050
[TBL] [Abstract][Full Text] [Related]
18. Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses.
Shamblin SL; Hancock BC; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2254-68. PubMed ID: 16941232
[TBL] [Abstract][Full Text] [Related]
19. Plasticization of poly(vinylpyrrolidone) thin films under ambient humidity: insight from single-molecule tracer diffusion dynamics.
Bhattacharya S; Sharma DK; Saurabh S; De S; Sain A; Nandi A; Chowdhury A
J Phys Chem B; 2013 Jun; 117(25):7771-82. PubMed ID: 23777572
[TBL] [Abstract][Full Text] [Related]
20. Rheological and mucoadhesive characterization of polymeric systems composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone), designed as platforms for topical drug delivery.
Jones DS; Lawlor MS; Woolfson AD
J Pharm Sci; 2003 May; 92(5):995-1007. PubMed ID: 12712419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
